Search Results
A Phase II study of I-SABR in early or recurrent NSCLC
Assessing I-SABR in early or recurrent non-small cell lung cancer
Outcomes of I-SABR in lung cancer
The future of I-SABR in lung cancer
Radiotherapy patterns of care for stage I and II non small cell lung cancer in Sydney, Australia
SPORT study: second primary lung cancer
VISION: tepotinib in MET exon 14 skipping NSCLC
Would early stage lung cancer recur after surgical resection?
Debate: SABR and limited resection in lung cancer
How Myriad's myPlan Addresses the Risk of Recurrence in Lung Cancer
ADAURA: osimertinib adjuvant therapy on CNS disease recurrence
Ask A Radiation Oncologist: Radiation Therapy for Lung Cancer
